Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v2.4.0.8
Consolidated Balance Sheets (USD $)
Mar. 31, 2013
Dec. 31, 2012
ASSETS    
Cash and cash equivalents $ 0 $ 123,000
Inventories 94,000 59,000
Prepaid expenses 0 20,000
Total Current Assets 94,000 202,000
Patents, net 24,000 24,000
Total Other Assets 24,000 24,000
TOTAL ASSETS 118,000 226,000
Current Liabilities:    
Bank overdraft 1,000 0
Accounts payable 883,000 878,000
Accrued interest 1,341,000 1,253,000
Accrued expenses 1,240,000 1,173,000
Line of credit 0 27,000
Warrant liability 18,000 1,378,000
Settlement note payable 695,000 702,000
Demand notes payable 63,000 63,000
Convertible debentures, net of discount of $515,000 and $809,000, current portion 619,000 463,000
Convertible debentures 547,000 625,000
Total Current Liabilities 5,407,000 6,562,000
Stockholders' Deficit:    
Convertible preferred stock - $0.001 par value; 15,000,000 shares authorized: Series C - 96,230 and 96,230 shares issued and outstanding at March 31, 2013 and December 31, 2012, respectively 1,000 1,000
Series H - 25,000 and 25,000 shares issued and outstanding at March 31, 2013 and December 31, 2012, respectively 0 0
Series I - 1,666,667 and 1,666,667 shares issued and outstanding at March 31, 2013 and December 31, 2012, respectively 2,000 2,000
Common stock - $0.001 par value; 600,000,000 shares authorized; 573,051,524 and 500,573,746 shares issued and outstanding at March 31, 2013 and December 31, 2012, respectively 573,000 501,000
Additional paid-in capital 82,709,000 82,216,000
Accumulated deficit (88,498,000) (88,966,000)
Noncontrolling interest (76,000) (90,000)
Total Stockholders' Deficit (5,289,000) (6,336,000)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 118,000 $ 226,000